OPK FY2025 SEC EDGAR DEF 14A #85 of 168 in industry

Opko Health, Inc. CEO pay ratio

The CEO earned $1.9M in FY2025 against median worker pay of $44,252 · Chemicals & Pharmaceuticals.

Chemicals & Pharmaceuticals peers All rankings
State
DE
Filing date
2026-04-30
Industry
Chemicals & Pharmaceuticals
Industry rank
#85/168

Data updated August 2026

Subscribe to Opko Health, Inc. CEO pay filing updates (RSS)

CEO-to-worker pay ratio
42:1
Below Average (Scale: 0–1000:1)
CEO pay
$1.9M
Median worker
$44,252

Answer first

Opko Health, Inc.'s FY2025 CEO total of $1.9M ranks #1164 of 1,423 complete filings; its 42:1 pay ratio ranks #1049. Dollar rank is not ratio rank.

According to the same FY2025 complete-filing cohort used on the rankings boards (CEO total, median worker, and ratio all present). Median worker pay is $44,252. Industry placement uses the FY2025 SIC-28 peer cohort (# 85 of 168, 50th percentile - above the industry median pay ratio). Figures come from Section 953(b) Dodd-Frank DEF 14A disclosures - not estimates. View all Chemicals & Pharmaceuticals companies.

Dollar rank
#1164
$1.9M of 1,423 FY2025
Ratio rank
#1049
42:1 of 1,423
Industry pct
50th
above the industry median pay ratio

How Opko Health, Inc. ranks nationally

Opko Health, Inc. CEO pay vs. every FY2025 complete filing

Total CEO compensation, the full national distribution, this company marked

$1,854,000 18th percentile higher than 18% of 1,423 companies

$0–$2,500,000: 304 companies (21%). This entry sits in this band. $2,500,000–$5,000,000: 182 companies (13%). Above this entry. $5,000,000–$7,500,000: 208 companies (15%). Above this entry. $7,500,000–$10,000,000: 192 companies (13%). Above this entry. $10,000,000–$12,500,000: 139 companies (10%). Above this entry. $12,500,000–$15,000,000: 91 companies (6%). Above this entry. $15,000,000–$17,500,000: 88 companies (6%). Above this entry. $17,500,000–$20,000,000: 54 companies (4%). Above this entry. $20,000,000–$22,500,000: 24 companies (2%). Above this entry. $22,500,000–$25,000,000: 34 companies (2%). Above this entry. $25,000,000–$27,500,000: 24 companies (2%). Above this entry. $27,500,000–$30,000,000: 16 companies (1%). Above this entry. $30,000,000–$32,500,000: 10 companies (1%). Above this entry. $32,500,000–$35,000,000: 7 companies (0%). Above this entry. $35,000,000–$37,500,000: 9 companies (1%). Above this entry. $37,500,000–$40,000,000: 6 companies (0%). Above this entry. $40,000,000–$42,500,000: 1 companies (0%). Above this entry. $42,500,000–$45,000,000: 1 companies (0%). Above this entry. $45,000,000–$47,500,000: 6 companies (0%). Above this entry. $47,500,000–$50,000,000: 27 companies (2%). Above this entry. This company $0 $50M+ every complete-filing company, bucketed by value

Each bar is a $2500K-wide band; taller bars hold more companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source SEC DEF 14A Section 953(b) disclosures, PlainCEOPay extract · FY2025

Opko Health, Inc. vs. Chemicals & Pharmaceuticals peers

CEO total pay ($1.9M) against pay ratio (42:1) for Opko Health, Inc. (marked) and its 4 closest same-industry peers, against the Chemicals & Pharmaceuticals industry median on both axes.

Pay + gap both highContained pay, wide gapHigh pay, contained gapBelow peer norms on both03398027.16796054.210194081.313592108.440.9:141.7:142.5:143.3:144.1:1CEO total payPay ratio (CEO : median worker)Opko Health, Inc., CEO total pay: 1854000 · Pay ratio (CEO : median worker): 42:1Opko Health, Inc.Regeneron Pharmaceuticals, Inc., CEO total pay: 7313796 · Pay ratio (CEO : median worker): 42:1Regeneron Pharmaceuticals, Inc.Emergent BioSolutions Inc., CEO total pay: 130553 · Pay ratio (CEO : median worker): 41:1Emergent BioSolutions Inc.Biocryst Pharmaceuticals Inc, CEO total pay: 12951082 · Pay ratio (CEO : median worker): 41:1Biocryst Pharmaceuticals IncOlaplex Holdings, Inc., CEO total pay: 149243 · Pay ratio (CEO : median worker): 44:1Olaplex Holdings, Inc.
Opko Health, Inc. vs. Chemicals & Pharmaceuticals peers, plotted against the industry's $7.9M median CEO total and 42:1 median pay ratio.

Ratio bands among Chemicals & Pharmaceuticals peers

Exclusive CEO-to-median-worker bands across 153 complete latest-FY filings in SIC 28. Segments sum to the peer set, not this company's compensation pillar.

CEO Compensation Breakdown, FY2025

A component-level pay breakdown is not reported in Opko Health, Inc.'s structured SEC pay-ratio disclosure. See our methodology →

Filing-year trail · Opko Health, Inc.

Complete DEF 14A pay-ratio filings for this CIK across FY2022–2025. Year-over-year deltas compare adjacent filing years only; incomplete dollar rows are omitted (same completeness gate as the hero figures).

Latest ratio
42:1
FY2025
vs prior FY
-5:1
from FY2024 47:1
CEO $ YoY
-14%
$1.9M latest
Filings shown
4
FY2022–2025
Opko Health, Inc. CEO total compensation, median worker pay, and pay ratio by fiscal year from SEC EDGAR DEF 14A.
FY CEO pay Δ pay Median worker Pay ratio Δ ratio
2022 $972K - $43,798 22:1 -
2023 $2.3M +134% $44,158 52:1 +30:1
2024 $2.2M -5% $45,683 47:1 -5:1
2025 $1.9M -14% $44,252 42:1 -5:1

Source: SEC EDGAR DEF 14A pay-ratio disclosures for CIK 944809, FY2022–2025. Adjacent-year deltas only.

Industry Comparison - Chemicals & Pharmaceuticals

This Company's Ratio
42:1
Industry Median Ratio
42:1
Industry Median CEO Pay
$7.9M
This CEO's Pay
$1.9M
Companies in Industry
168
vs. Industry Median
Below
#85 of 168 by pay ratio in this industry View all companies in Chemicals & Pharmaceuticals →

Opko Health, Inc.: MODEST · LIGHT pay ratio

Opko Health, Inc.'s FY2025 CEO total $1.9M ranks #1164 of 1,423 complete filings (lower third by dollars). the CEO earned 42× the median employee ($44,252) in FY2025.

Median employee $44,252 (PAR-MED); MODEST · LIGHT stamps put about 42 median-wage years per CEO year.

CEO Total Pay

$1.9M

FY2025 Summary Compensation, below median

Pay Ratio

42:1

Below typical

Opko Health, Inc. in the lower-dollar third

Opko Health, Inc.'s FY2025 CEO total $1.9M ranks #1164 of 1,423 complete filings (lower third by dollars). The structured pay-ratio disclosure reports the total without line-item components. Chemicals & Pharmaceuticals (SIC 28) median ratio is 42:1 across 168 FY2025 filers; Opko Health, Inc.'s $1.9M CEO total is at or below the $7.9M industry median CEO pay.

Dollar rank #1164 and ratio rank #1049 split - treat 42:1 as a disclosure, not a fairness score. Open Chemicals & Pharmaceuticals peers.

Key Data, FY2025

Total Compensation
$1.9M
Median Employee Pay
$44,252
Pay Ratio
42:1
Filing Date
2026-04-30

Company Info

Ticker
OPK
CIK
944809
Industry
Chemicals & Pharmaceuticals
SIC Code
2834
State
DE
View SEC filings →
SEC EDGAR DEF 14A for CIK 944809, FY2025. Informational only, not investment advice. Verify on EDGAR.

Read our methodology - how this data is sourced, computed, and verified. Opko Health, Inc.'s FY2025 CEO total $1.9M ranks #1164 of 1,423 complete filings (lower third by dollars).

Read with Opko Health, Inc.

ABS(ceo_total_comp) peers first, then a SIC pole and a stamp-branched guide - not a fixed Related strip. This page stamps MODEST · LIGHT · PAR-MED.

ST JOE Co · LIGHT

ABS(ceo_total_comp) peer at $1.9M (Δ $4K heavier vs Opko Health, Inc.); MODEST · PAR-MED vs this page's MODEST · LIGHT · PAR-MED.
Clarus Corp · LIGHT

ABS(ceo_total_comp) peer at $1.9M (Δ $10K heavier vs Opko Health, Inc.); MODEST · PAR-MED vs this page's MODEST · LIGHT · PAR-MED.
Wilson Bank Holding Co · LIGHT

ABS(ceo_total_comp) peer at $1.8M (Δ $22K lighter vs Opko Health, Inc.); MODEST · PAR-MED vs this page's MODEST · LIGHT · PAR-MED.
Great Southern Bancorp, Inc. · LIGHT

ABS(ceo_total_comp) peer at $1.8M (Δ $38K lighter vs Opko Health, Inc.); MODEST · LOW-MED vs this page's MODEST · LIGHT · PAR-MED.
Regeneron Pharmaceuticals, Inc. (SIC 28 pole)

Regeneron Pharmaceuticals, Inc. stamps MODEST · HEAVY nearest in-SIC by ABS(pay_ratio) to Opko Health, Inc.'s MODEST filing.
National dual ranks · #1164/#1049

Opko Health, Inc.'s FY2025 package sits #1164 by CEO dollars and #1049 by ratio under LIGHT · MODEST.
Ratio primer · MODEST

Opko Health, Inc.'s MODEST stamp sits in the lower Item 402(u) band - start with how the ratio is disclosed before comparing peers.
Data sourced from SEC EDGAR DEF 14A for Opko Health, Inc. (CIK 944809), FY2025. See our methodology. Aggregated by PlainCEOPay as of August 2026.

Data currency: Executive compensation from SEC EDGAR DEF 14A proxy statements through fiscal year 2025, compiled and last refreshed August 2026. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.